{
  "id": 10980237,
  "title": "Higher GLP-1 costs lead to lower adherence",
  "url": "https://urgent.news/2026/09/30/higher-glp-1-costs-lead-to-lower-adherence",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-30T16:02:47.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-higher-glp-adherence.html"
  },
  "original_language": "en",
  "account": "A new University of Georgia study reveals that high out-of-pocket costs for GLP-1 weight loss medications are significantly reducing patient adherence. Even at the lowest cost tier of $0–$21, three-quarters of patients stopped taking the medication within a year. However, when monthly out-of-pocket expenses exceeded $75, nonadherence rates soared above 80%. Lead researcher Eunhae Shin attributes this trend to the financial barriers faced by patients, particularly those with employer-sponsored insurance that lacks price caps on GLP-1s. The study, published in JAMA Health Forum, found that adherence was lowest—around 17%—among patients paying more than $168 per month, a group that often includes individuals with high-deductible insurance plans. While the study did not directly analyze socioeconomic factors, previous research indicates that low-income populations are more likely to enroll in plans with high cost-sharing and low premiums, leading to greater financial burdens on GLP-1 medications. Despite the short-term costs, Shin hopes future research will demonstrate long-term economic benefits, as effective weight loss medications could reduce healthcare costs by preventing chronic conditions and emergency room visits.",
  "summary": "Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication as prescribed, often because of high out-of-pocket costs.",
  "key_points": [
    "High out-of-pocket costs for GLP-1 medications reduce patient adherence.",
    "Nonadherence rates exceed 80% when monthly expenses surpass $75.",
    "Adherence is lowest among patients paying over $168 per month."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}